-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$57.2528.08% Upside
Recent Analyst Forecasts and Stock Ratings
Mirum Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. has been rated by research analysts at Stifel Nicolaus, Robert W. Baird, Evercore ISI, Morgan Stanley, H.C. Wainwright, Cantor Fitzgerald in the past 90 days.